Request a Consultation


CIGC Responds to FDA Warning Recommendation for Power Morcellators


Yesterday, the FDA announced a recommendation to all manufacturers of power morcellation tools, stating that there should be a boxed warning to indicate the tool may spread cancer during GYN surgeries.

Below, The Center for Innovative Care (CIGC) responds to this recommendation by outlining why the use of power morcellation  is so prevalent, yet completely unnecessary for the advanced laparoscopic surgeons at CIGC and their innovative GYN surgical techniques.

In minimally invasive surgery, removal of fibroids from the uterus, or the entire uterus itself, usually requires the use of a “power morcellator” to extract the fibroid tissue from the body. Although there are significant benefits to doing fibroid removal with small incisions and power morcellators have been used extensively to keep the incisions small, this tool is not necessary and puts patients at potential risk. The FDA warning on power morcellation was issued to make sure that patients understand the risk for cancer spread when morcellators are used in those situations in which the fibroids contain cancer.

At the Center for Innovative GYN Care, power morcellators are never used for fibroid removalUsing unique techniques, fibroids can be removed easily and safely with the smallest incisions possible and the fastest recovery.  By making power morcellators “obsolete”, CIGC ensures safer procedures for patients. Elimination of power morcellators also keeps the incisions smaller. Procedures are performed faster and more effectively, with a far better recovery and at lower cost. These are the reasons CIGC has not used power morcellation in the past, and will continue this practice in the future to ensure safer and more effective surgical procedures for its patients.

Visit for more information on the revolutionary techniques.

Book a consultation with one of CIGC’s doctors: Paul Mackoul, MD; Natalya Danilyants, MD; Britton Chahine, MD here.

Book a Consult Today

  • What condition or procedure are you interested in?

  • By sending us an email, you acknowledge that you have read, understand and agree to our Privacy Policy and Terms of Service. Please do not include confidential personal information and never include your Social Security Number, your date of birth, or any insurance/financial information in any email to CIGC. The internet is not absolutely secure, and CIGC’s email system is not encrypted.

    “Book a Consult” feature is provided as a courtesy for individuals to initiate conversation with CIGC. Contacting CIGC through this feature is not intended to create, and does not create, a new patient relationship with CIGC or any of its health care providers.

    Testimonials or statements made by any person(s) within this site are not a guarantee as to outcomes.

    Examples of treatment outcomes in this website are not intended to convey and warranty, either express or implied, as to outcomes, promises, or benefits from treatment. Every patient is treated on a case-by-case basis. The content of this site is not a substitute for medical advice, care or evaluation by a medical professional.

  • This field is for validation purposes and should be left unchanged.

Related Articles

Hospital & Healthcare Management | ASC Expansion of GYN Surgery to Patients in Rural Areas

April 18, 2019

“Regardless of where they live or what they do, patients should never have to undergo any open procedure when there is a b…

Read article

EverydayHealth | Dr. Natalya Danilyants Discusses Adenomyosis, Sheds Light on this Obscure Disease

April 10, 2019

“While causes are still just theoretical, there are significant risk factors that doctors should pay attention to when dia…

Read article

Two Abstracts by CIGC Selected for Presentation at the 2019 Society of Gynecologic Surgeons Annual Meeting

April 1, 2019

New Data on Effectiveness and Safety of Laparoscopic-Assisted Myomectomy to be Highlighted.
WASHINGTON, DC (April 1, 2019…

Read article